FiercePharma

Novartis introduces Lucentis® in state of the art pre-filled syringe

Novartis announces the launch in Europe of the Lucentis pre-filled syringe (PFS), which is specifically designed for intraocular injection The Lucentis PFS can lead to improved patient treatment via a ...
Business Wire

FDA Approves Genentech’s Lucentis (ranibizumab injection) 0.3 mg Prefilled Syringe for Diabetic Macular Edema and Diabetic Retinopathy

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) approved the ...
Monthly Prescribing Reference

Additional Strength of Lucentis Prefilled Syringe FDA-Approved

The 0.3mg PFS marks the first approved syringe with an anti-vascular endothelial growth factor (VEGF) to treat all forms of diabetic retinopathy with or without diabetic macular edema (DME). Genentech ...
Yahoo Finance

Polpharma Biologics announces commercial launch of Europe’s first Pre-filled Syringe presentation of a ranibizumab biosimilar

ZURICH, October 21, 2025--(BUSINESS WIRE)--Polpharma Biologics today announced Ranivisio® PFS (ranibizumab biosimilar pre-filled syringe), is now commercially available in France. Ranivisio® is the ...
AFP

Pre-filled Syringe Presentation of BYOOVIZ®, Samsung Bioepis' Biosimilar to Lucentis (Ranibizumab), Gains European Approval

Samsung Bioepis Co., Ltd. today announced that the European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for BYOOVIZ ® pre-filled ...
Becker's Hospital Review

FDA approves new method to administer Genentech’s Lucentis: 3 things to know

Genentech earned FDA approval for a new method of administering its 0.3 milligram eye drug Lucentis March 21. Here are three things to know. 1. The drugmaker will now offer a 0.3 milligram prefilled ...
FiercePharma

Novartis hits setback in bid to block Regeneron's Eylea prefilled syringe as dual lawsuits drag on

Novartis won’t be able to block Regeneron’s popular Eylea prefilled syringe any time soon after a regulatory setback. But the Lucentis maker isn’t giving up on the patent fight that could shift the ...
AFP

Polpharma Biologics announces commercial launch of Europe’s first Pre-filled Syringe presentation of a ranibizumab biosimilar

Polpharma Biologics today announced Ranivisio® PFS (ranibizumab biosimilar pre-filled syringe), is now commercially available in France. Ranivisio® is the first Lucentis® biosimilar which is offered ...
Finanznachrichten

Samsung Bioepis Co., Ltd.: Pre-filled Syringe Presentation of BYOOVIZ, Samsung Bioepis' Biosimilar to Lucentis (Ranibizumab), Gains European Approval

European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) adopts positive opinion for BYOOVIZ (ranibizumab) pre-filled syringe (PFS) PFS presentation to become available ...
Finanznachrichten

Polpharma Biologics announces commercial launch of Europe's first Pre-filled Syringe presentation of a ranibizumab biosimilar

Polpharma Biologics today announced Ranivisio® PFS (ranibizumab biosimilar pre-filled syringe), is now commercially available in France. Ranivisio® is the first Lucentis® biosimilar which is offered ...
Yahoo Finance

Pre-filled Syringe Presentation of BYOOVIZ®, Samsung Bioepis' Biosimilar to Lucentis (Ranibizumab), Gains European Approval

INCHEON, Korea, December 02, 2025--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. today announced that the European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) has ...